XM does not provide services to residents of the United States of America.
W
W

Waters


News

Mettler-Toledo beats quarterly profit estimates on strong demand for its lab instruments

Mettler-Toledo beats quarterly profit estimates on strong demand for its lab instruments Nov 7 (Reuters) - Medical equipment maker Mettler-Toledo International MTD.N beat third-quarter profit estimates on Thursday, helped by increased demand for its laboratory instruments used in drug development and research. The company also raised the lower end of its annual profit forecast to the range of $40.35 to $40.50 per share, compared to its previous estimate of $40.20 to $40.50 apiece .
W
M

U.S. STOCKS Cencora, Charles River, Howmet Aerospace

BUZZ-U.S. STOCKS ON THE MOVE-Cencora, Charles River, Howmet Aerospace Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes soared to record highs on Wednesday, as Republican Donald Trump won the 2024 U.S. presidential election in a remarkable comeback four years after he was voted out of the White House.
P
U
U
H
L
T
W
H
U

Contract research organizations gain after Trump win

BUZZ-Contract research organizations gain after Trump win ** Shares of contract research organizations up 1% to 3% premarket after Donald Trump is elected U.S. president for a second term ** Thermo Fisher Scientific TMO.N up 2%, Danaher DHR.N up 1.9%, Icon ICLR.O up 1.6% and Waters WAT.N up 2.8% ** "Any potential changes to the Inflation Reduction
T
W

U.S. Amazon, Chevron, Mastercard

U.S. RESEARCH ROUNDUP-Amazon, Chevron, Mastercard Nov 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amazon, Chevron and Mastercard, on Monday. HIGHLIGHTS * Amazon AMZN.O : Raymond James raises target price to $230 from $205 * Chevron Corp CVX.N : Raymond James raises target price to $175 from $170 * Mastercard MA.N : Macquarie raises target price to $565 from $505 * Vertex Inc VERX.O : Jefferies raises to buy fro
A
A
A
B
C
C
D
E
G
M
S
A
T
W
B
C
R
T

Waters soars after raising annual profit forecast

BUZZ-Waters soars after raising annual profit forecast ** Shares of lab equipment and software maker Waters WAT.N rise 17.1% to $378.40, its highest since 2021 ** Co raises its annual adj. profit forecast to $11.67 to $11.87 per share, from $11.55 to $11.65 per share ** WAT reports Q3 adj. profit of $2.93/shr vs analysts' average estimate of $2.68/
W

U.S. STOCKS Wayfair, B. Riley, Church & Dwight

BUZZ-U.S. STOCKS ON THE MOVE-Wayfair, B. Riley, Church & Dwight Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock futures rose on Friday, buoyed by strong Amazon results offsetting the previous session's tech selloff, with investors awaiting nonfarm payrolls data for insights on the Federal Reserve's key policy rate trajectory.
A
A
A
B
C
I
S
U
I
W
C
H

Waters Corp raises annual profit forecast on higher demand for lab equipment

Waters Corp raises annual profit forecast on higher demand for lab equipment Nov 1 (Reuters) - Waters Corp WAT.N raised its annual profit forecast after beating Wall Street estimates for third-quarter profit and revenue on Friday, on improved demand for its products and services used in drug development and research. The lab equipment and software maker expects its 2024 adjusted profit to be between $11.67 and $11.87 per share, compared with its prior forecast of $11.55 to $11.65 per share.
T
W

Waters Q3 Adjusted EPS USD 2.93 Vs. IBES Estimate USD 2.68

BRIEF-Waters Q3 Adjusted EPS USD 2.93 Vs. IBES Estimate USD 2.68 Nov 01 (Reuters) - Waters Q3 sales USD 740 million vs. IBES estimate USD 713 million. Q3 EPS USD 2.71 outlook FY sales growth -0.9 to -0.3% outlook FY adjusted EPS USD 11.67-11.87
W

U.S. STOCKS Avery Dennison, Snap-On, Avadel Pharma

BUZZ-U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street gained on Thursday, with the S&P 500 and the Dow touching intraday record highs, driven by TSMC's upbeat forecast and a bigger-than-expected rise in monthly retail sales indicating a strong U.S.
A
B
C
E
I
N
N
R
S
S
S
U
U
U
U
T
U
W
W
A
E
M
S

U.S. STOCKS PPG Industries, Travelers, ShiftPixy

BUZZ-U.S. STOCKS ON THE MOVE-PPG Industries, Travelers, ShiftPixy Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were set to rise on Thursday, with an upbeat forecast from TSMC boosting semiconductor stocks, while a bigger-than-expected rise in September retail sales pointed to a strong U.S.
A
A
B
C
C
E
I
N
R
S
U
U
S
T
U
W
W
P
R

US life sciences firms get lift from Sartorius' results

BUZZ-US life sciences firms get lift from Sartorius' results ** Shares of US life sciences firms rise after German peer Sartorius's SATG.DE better-than-expected bioprocessing order intake in its nine-month results ** Premarket, Danaher DHR.N up 3.4%, Thermo Fisher Scientific TMO.N up 2.1% and Waters WAT.N up 1.7% ** Sartorius' order intake rose 6.6
T
W

U.S. STOCKS Wave Life Sciences, Dominion Energy, Voyager Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq were little changed on Wednesday, with declines in heavily weighted technology megacaps limiting gains as investors turned to small-cap and financial stocks after a slew of upbeat bank earnings.
A
A
I
J
S
U
U
G
T
W
A

U.S. STOCKS Wave Life Sciences, Dominion Energy, Voyager Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics The Dow regained some lost ground on Wednesday although the S&P 500 and the Nasdaq stumbled, dragged lower by declines in megacap technology stocks, while the broader market gained from upbeat quarterly earnings from banks, notably Morgan Stanley. .N At 11:32 ET, the Dow Jones Industrial Average .DJI was up 0.4% to 42,924.64 at 11:34, pares gain.
A
A
C
D
I
S
J
U
U
U
G
T
W
A

U.S. STOCKS United Airlines, Morgan Stanley, Autodesk

BUZZ-U.S. STOCKS ON THE MOVE-United Airlines, Morgan Stanley, Autodesk Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were on track for a muted open on Wednesday, following a selloff in tech and oil stocks in the previous session, as investors parsed quarterly results from banks including Morgan Stanley.
A
A
C
I
A
J
U
U
U
I
W
A

U.S. STOCKS Gold miners, J.B. Hunt, Cisco Systems

BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, J.B. Hunt, Cisco Systems Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures were largely subdued on Wednesday, following a selloff in tech and oil stocks in the previous session, as investors awaited quarterly results from Morgan Stanley and other banks.
C
I
A
J
U
W

Bernstein expects a 'not so scary' Q3 for US life sciences firms

BUZZ-Bernstein expects a 'not so scary' Q3 for US life sciences firms ** Brokerage Bernstein expects a "not so scary" Q3 earnings season for U.S. life sciences and tools firms, which "would be a real treat" for investors ** "With the recovery timeline for life science tools continuing to push out (further), some investors feel like they have been t
A
I
T
W

U.S. Humana, Portillos, Waters Corp

U.S. RESEARCH ROUNDUP-Humana, Portillos, Waters Corp Oct 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Humana, Portillos and Waters on Tuesday. HIGHLIGHTS * Frontier Communications Parent Inc FYBR.O : TD Cowen cuts to hold from buy * Humana HUM.N : RBC cuts target price to $265 from $400 * Portillos Inc PTLO.O : Stephens cuts to equal-weight from overweight * Waters Corp WAT.N : Jefferies raises to buy from hold
B
C
C
C
H
C
F
G
S
W
C
C
P

U.S. STOCKS Gold miners, silver miners, Warner Bros Discovery

BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street was little changed on Thursday after hot producer prices data kept a smaller, 25-basis-point interest-rate cut by the Federal Reserve firmly on the table, while vaccine maker Moderna's shares slumped following a downbeat revenue forecast.
G
K
M
U
U
D
W
A



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.